XIFIN Ranked as a Fastest Growing Company in North America on Deloitte’s 2010 Technology Fast 500™

Growth Stimulated by Increased Demand for Specialized Revenue Cycle Management Solutions

SAN DIEGO--(BUSINESS WIRE)-- XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, today announced that it ranked on the Technology Fast 500™, Deloitte’s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the period from 2005–2009.

Designed around industry best practices, and used by the majority of the nations’ largest laboratories, XIFIN’s revenue cycle management system is proven to deliver improved cash collections and reduced operational costs for a wide variety of providers across various industries, including anatomic pathology, molecular, toxicology, radiology and more. XIFIN is an active advocate on behalf of diagnostic service providers, participating with trade associations, standards committees and third party payors in the development of sound medical reimbursement policies and practices.

XIFIN’s chief executive officer, Lale White, credits the company’s revenue growth to the growing demand for cost-effective revenue cycle management systems that meet the complex needs of diagnostic service providers. “Our team is dedicated to providing automated Software-as-a-Service (SaaS) solutions that meet the challenging reimbursement needs of diagnostic service providers and help optimize operations and improve net cash collections. We are honored to be ranked on Deloitte’s Technology Fast 500™. Following XIFIN being recently named to the 2010 Inc. 5000 list of fastest-growing private companies for the fourth consecutive year, this has been an exceptional year for public recognition of our efforts.”

“XIFIN, Inc. and the other 2010 Technology Fast 500™ winners forged ahead in a challenging economic environment to realize exceptional growth,” said Phil Asmundson, vice chairman and Deloitte’s U.S. technology, media and telecommunications leader. "Deloitte commends XIFIN for this impressive accomplishment.”

“XIFIN has proved itself to be one of the fastest growing tech companies in North America, and we are proud to honor them as one of the 2010 Technology Fast 500™,” said Mark Jensen, managing partner, venture capital services, Deloitte & Touche LLP.

For additional detail on the Technology Fast 500™ including selection and qualifying criteria, visit www.fast500.com.

About XIFIN

XIFIN is a Software-as-a-Service (SaaS) provider of revenue cycle management solutions that help diagnostic service providers improve financial performance and enhance operational efficiency with a compelling return on investment and rapid time-to-value. The company has received continual industry recognition, including being named to the Inc. 5000 fastest growing privately-held companies 2007 through 2010, and ranking among Deloitte’s Technology Fast 500. To learn how XIFIN uniquely delivers revenue cycle management, visit www.XIFIN.com.

As used in this document, “Deloitte” means Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.



CONTACT:

XIFIN, Inc.
Bill Taylor, 858-436-2995
Vice President, Marketing
[email protected]
or
Myla Wagner Public Relations
Myla Wagner, 925-736-7515
[email protected]

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Health  Hospitals  Professional Services  Finance

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.